article thumbnail

Appeals Court resurrects PhRMA's lawsuit challenging pricing provisions in IRA

Fierce Pharma

For trade group the Pharmaceutical Research and Manufacturers of America (PhRMA), the fight against pricing provisions in the Inflation Reduction Act isn’t over yet. Late last week, the U.S.

article thumbnail

PhRMA seeks to revive Medicare price negotiations lawsuit, blasts Biden's request for IRA expansion

Fierce Pharma

As President Joe Biden doubles down on the price negotiation meas | As President Joe Biden doubles down on the price negotiation measures in the Inflation Reduction Act, prominent industry lobbying group the Pharmaceutical Research and Manufacturers of America isn’t letting its legal challenge go down without a fight.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PhRMA joins legal battle over Inflation Reduction Act's 'price-setting' measures

Fierce Pharma

After Merck and Bristol Myers Squibb took shots at the Inflation Reduction Act (IRA) in separate lawsuits, influential trade group Pharmaceutical Research and Manufacturers of America (PhRMA)—plus | Trade group PhRMA is the latest to go after the IRA in a lawsuit claiming violations of the Fifth and Eighth amendments.

article thumbnail

Why is microbiological testing in medical device manufacturing important?

European Pharmaceutical Review

A paper published in the Journal of Pharmaceutical Research International has reviewed microbiological testing for medical devices and described their applications and challenges. This approach can also help determine the appropriate manufacturing processes, sterilisation methods, and maintenance procedures. Sharma et al.

article thumbnail

After Pfizer's exit, UCB splits from industry trade group BIO

Fierce Pharma

UCB will still retain its membership in other top trade groups, including the Pharmaceutical Research and Manufacturers Association of America (PhRMA). . | Both companies opted not to renew their 2024 memberships with the Biotechnology Innovation Organization (BIO).

article thumbnail

CPHI to return to Milan in 2024

European Pharmaceutical Review

The exhibition, which will take place from 8-10 October 2024, is being hosted in Milan for the second time in three years in recognition of the massive pharmaceutical ingredients and manufacturing industry in the region. The post CPHI to return to Milan in 2024 appeared first on European Pharmaceutical Review.

article thumbnail

Optimising drug release of personalised 3D printed tablets

European Pharmaceutical Review

The excipient matrix material selected for the tablets was PVA, the authors stated, as they intended for the dissolution process to be completed in “a few hours instead of over 20 [hours]” In terms of design, the printed tablets were manufactured “with 100 percent infill density”. This paper is published in Pharmaceutical Research.